The Cooper Companies, Inc. (NASDAQ:COO) Stock Rated "Hold" by Wall Street Brokerages

Key Points

• Analyst consensus is “Hold”: Of 19 brokerages covering Cooper Companies, 12 rate it a hold, five recommend buying, and two recommend selling. The average 12-month price target is $71.47.
• Shares have weakened significantly: Cooper Companies opened at $55.38, near its 12-month low of $51.01 and well below its 50-day and 200-day moving averages of $68.34 and $67.77, respectively.
• The company authorized a major buyback: Its board approved a $3 billion stock-repurchase program, allowing the company to buy back up to 22.7% of outstanding shares. The company also modestly exceeded quarterly EPS expectations, reporting $1.15 versus the $1.12 consensus.

The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) has earned a consensus recommendation of "Hold" from the nineteen brokerages that are presently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have assigned a buy rating to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $71.47.

Several research firms recently weighed in on COO. Weiss Ratings raised Cooper Companies from a "sell (d)" rating to a "hold (c-)" rating in a report on Friday, September 18th. Wells Fargo & Company set a $61.00 price objective on Cooper Companies and gave the stock an "equal weight" rating in a research report on Thursday, September 10th. BNP Paribas Exane lowered their price objective on Cooper Companies from $95.00 to $92.00 and set an "outperform" rating on the stock in a research report on Monday, June 8th. Needham & Company LLC dropped their target price on Cooper Companies from $86.00 to $73.00 and set a "buy" rating for the company in a report on Thursday, September 10th. Finally, Mizuho set a $75.00 target price on shares of Cooper Companies and gave the company an "outperform" rating in a research report on Thursday, September 10th.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, Director Lawrence Kurzius bought 10,000 shares of the stock in a transaction dated Wednesday, September 16th. The shares were bought at an average cost of $54.93 per share, with a total value of $549,300.00. Following the completion of the acquisition, the director owned 31,099 shares of the company's stock, valued at $1,708,268.07. This trade represents a 47.40% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Walter M. Rosebrough, Jr. purchased 3,000 shares of the company's stock in a transaction dated Monday, September 14th. The stock was acquired at an average price of $54.29 per share, with a total value of $162,870.00. Following the completion of the transaction, the director owned 20,000 shares of the company's stock, valued at $1,085,800. This represents a 17.65% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders acquired 34,701 shares of company stock valued at $1,880,039 in the last quarter. Company insiders own 2.08% of the company's stock.

Hedge Funds Weigh In On Cooper Companies

Hedge funds have recently added to or reduced their stakes in the stock. Avalon Trust Co bought a new stake in shares of Cooper Companies during the 2nd quarter valued at $25,000. Root Financial Partners LLC increased its position in shares of Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company's stock worth $26,000 after purchasing an additional 162 shares during the period. SJS Investment Consulting Inc. increased its position in shares of Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company's stock worth $26,000 after purchasing an additional 187 shares during the period. Elevation Wealth Partners LLC increased its position in shares of Cooper Companies by 1,136.4% in the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company's stock worth $29,000 after purchasing an additional 375 shares during the period. Finally, Continuum Advisory LLC acquired a new position in Cooper Companies in the second quarter valued at about $30,000. Institutional investors own 24.39% of the company's stock.

Cooper Companies Price Performance

Cooper Companies stock opened at $55.38 on Friday. The company's 50-day moving average price is $68.34 and its two-hundred day moving average price is $67.77. The company has a quick ratio of 0.73, a current ratio of 1.22 and a debt-to-equity ratio of 0.23. The stock has a market cap of $10.53 billion, a P/E ratio of 18.90, a P/E/G ratio of 2.25 and a beta of 0.82. Cooper Companies has a twelve month low of $51.01 and a twelve month high of $89.83.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Wednesday, September 9th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.12 by $0.03. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%.The company had revenue of $1.07 billion during the quarter, compared to analysts' expectations of $1.10 billion. During the same quarter in the previous year, the company posted $0.49 earnings per share. The business's revenue was up .5% on a year-over-year basis. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. As a group, analysts expect that Cooper Companies will post 4.53 EPS for the current year.

Cooper Companies announced that its Board of Directors has authorized a stock repurchase program on Wednesday, September 9th that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the medical device company to buy up to 22.7% of its stock through open market purchases. Stock repurchase programs are often a sign that the company's leadership believes its shares are undervalued.

Cooper Companies Company Profile

Cooper Companies, Inc is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company develops, manufactures and markets products through two primary business segments: CooperVision and CooperSurgical.

CooperVision specializes in contact lenses, including daily disposable, toric, multifocal, multifocal toric, specialty and myopia-management lenses. Its products are designed to address a range of vision-correction needs, including astigmatism, presbyopia and irregular corneas.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.